Table 3.
Comparisons of most common diagnoses before and during the COVID-19 pandemic.
| Pre-COVID-19 |
During COVID-19 |
||||
|---|---|---|---|---|---|
| Diagnosis | Number (%) | Site | Diagnosis | Number (%) | Site |
| Impacted cerumen | 23 (9.4%) | E | Tinnitus | 4 (16.0%) | E |
| Otitis media | 22 (9.0%) | E | Vertigo/dizziness | 3 (12.0%) | E |
| Chronic otitis externa | 20 (8.2%) | E | Vocal cord disorders | 3 (12.0%) | T |
| Tinnitus | 16 (6.5%) | E | Impacted cerumen | 2 (08.0%) | E |
| Oral mucositis | 15 (6.1%) | T | Chronic otitis externa | 2 (08.0%) | E |
| Vertigo/dizziness | 14 (5.7%) | E | Otalgia | 2 (08.0%) | E |
| Chronic rhinitis | 12 (4.9%) | N | Chronic rhinitis | 2 (08.0%) | N |
| Hearing loss | 11 (4.5%) | E | Chronic pharyngitis | 2 (08.0%) | T |
| Oral leukoplakia | 11 (4.5%) | T | – | – | – |
| Chronic rhinosinusitis | 10 (4.1%) | N | – | – | – |
| Total | 62.9% | Total | 80.0% | ||
Abbreviations: E: ear; N: nose; T: throat.